WEBINAR: DSCSA - 13 Year Implementation & 2024 Update
| Overview / Abstract: |
The Drug Supply Chain Security Act (DSCSA), enacted in 2013, is approaching its final implementation phase. This 1-hour CE session will review the step-by-step implementation process and provide an important update for 2024 and beyond. By November 27, 2026, pharmacies must comply with FDA enforcement requirements to electronically exchange transaction information and conduct package-level verification. This involves implementing systems for serialized transaction data, ensuring quick access to records, and developing SOPs for regulatory or trading partner requests. While small dispensers have an exemption until November 27, 2026, pharmacies should still focus on making compliant purchases and maintaining accurate inventory records as required by Pharmacy Benefit Manager (PBM) Provider Manuals. PBM audits remain ongoing to verify inventory sourcing, regardless of DSCSA exemptions. Start preparing now to stay compliant with these critical updates. Click the following link to learn more and register: https://www.lecturepanda.com/a/DSCSA2024, or click "Access Activity" below. |
|
Expiration |
Sep 10, 2027 |
|
Discipline(s) |
Pharmacy CPE |
|
Format |
Online, Webinar / Webcast / Video |
|
Cost |
Members: $20 | Non-Members: $30 | Special Pricing for Student Pharmacists |
|
Credits / Hours |
1 |
|
Accreditation |
The American College of Apothecaries (ACA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACA has accredited this program for 1 contact hour (0.1 CEU) of continuing education credit for pharmacists and pharmacy technicians. |
|
Presenters / Authors / Faculty |
Martha M. Rumore, PharmD, JD, MS, LLM, FAPhA Martha M. Rumore, PharmD, Esq, MS, LLM, FAPhA, is a pharmacist-attorney and registered patent attorney in Frier Levitt’s Life Sciences Department, where she leads the firm’s Intellectual Property team. She has extensive experience in healthcare law, FDA and regulatory matters, 503A/503B compounding, pharmacy law, PBM audits, and DSCSA compliance. With over 25 years of experience across health systems, the pharmaceutical industry, and law firms, Dr. Rumore regularly advises on USP <797>/<795>/<800> compliance, regulatory submissions, and compounding practices. She has taught pharmacy and FDA law at multiple institutions and has authored more than 200 publications and presentations. |
|
Keywords / Search Terms |
American College of Apothecaries, Pharmacists, Pharmacy Stakeholders, Pharmacy, Drug Supply Chain Security Act, Deadlines, Compliance, Regulatory Requirements, FDA, Serialized Transaction Information, PBM Audits, Inventory Compliance, Small Dispenser Exemption, Transaction Data Requirements, DSCSA Package-Level Verification, CE Session, Webinar, Seminar, Continuing Education |
|